INTRODUCTION
============

As living standards improve, people are more demanding for high-quality food. Importantly, intramuscular fat (IMF) is a major determinant of meat quality ([@b28-ajas-26-7-1012-15]). The sensory traits of meat products are indeed influenced by the amount of intramuscular fat ([@b23-ajas-26-7-1012-15]). However, selection for leanness over the last 21 years in swine has decreased intramuscular fat and adversely influenced pork flavor and color ([@b42-ajas-26-7-1012-15]). Recently, intramuscular adipose tissue has attracted more attentions of the researchers, in attempt to maintain or improve the meat quality, by the high demand for the marbling fat ([@b13-ajas-26-7-1012-15]; [@b4-ajas-26-7-1012-15]; [@b9-ajas-26-7-1012-15]).

Thiazolidinediones (TZD) are a class of pharmaceutical agents currently used in the treatment of type-2 diabetes mellitus; they are also known as adipogenic compounds ([@b11-ajas-26-7-1012-15]). TZD are high-affinity ligands for peroxisome proliferator-activated receptor gamma (PPARγ) ([@b26-ajas-26-7-1012-15]), the critical factor for adipocyte differentiation ([@b6-ajas-26-7-1012-15]). It has been reported that TZD has physiologically relevant effects on the adipose tissue and the potential to modify intramuscular or marbling adipogenesis ([@b39-ajas-26-7-1012-15]; [@b16-ajas-26-7-1012-15]). *In vitro* experiment, [@b33-ajas-26-7-1012-15] has found TZD could lead to more adipocytes and larger cell size in adipose tissue of Zucker rat. The findings of Bouraoui et al. (2011) showed the simultaneous presence of TZD and insulin significantly increased the content of triglycerides in rainbow trout adipocyte cells. *In vivo* experiment, increased intramuscular lipid accumulation has been observed in TZD treated rodents and humans ([@b34-ajas-26-7-1012-15]; [@b38-ajas-26-7-1012-15]; [@b27-ajas-26-7-1012-15]). However, limited research has investigated the effect of TZD in meat animals, such as pig.

Several genes expressed in the muscle may be involved in the function of TZD, including PPARγ coactivator 1 (PGC-1), glucose transporter 4 (GLUT4) and fatty acid-binding protein 3 (FABP3) ([@b54-ajas-26-7-1012-15]; [@b29-ajas-26-7-1012-15]). PGC-1 is a transcriptional co-activator of PPARγ, its mRNA expression level can evaluate the effect of TZD as an agonist ([@b20-ajas-26-7-1012-15]). GLUT4 plays an important role in maintaining glucose homeostasis in mammals and mediating insulin-stimulated glucose uptake in adipocytes and muscle ([@b1-ajas-26-7-1012-15]; [@b57-ajas-26-7-1012-15]). It was found that activation of PPARγ in fibroblasts can stimulate the synthesis of GLUT4 of adipocytic cells ([@b56-ajas-26-7-1012-15]). Functionally, FABPs are intracellular proteins that transport fatty acids from the cell membrane to sites of fatty acid oxidation or triacylglycerol synthesis. Previously, genetic variants of both heart (H) and adipocyte (A) fatty acid-binding protein (FABP) genes (FABP3 and FABP4) were shown to be associated with IMF content, back fat thickness, and growth ([@b14-ajas-26-7-1012-15]). We hypothesized that dietary TZD supplementation could increase the marbling fat content and improve the meat quality in finishing pigs, and the expression of the foregoing genes might be modified by TZD.

Presently, few studies have considered TZD as a dietary supplement. The main objective of the current experiment was to investigate the effects of TZD supplementation on growth performance, serum parameters and intramuscular fat of finishing pigs.

MATERIALS AND METHODS
=====================

Materials
---------

Thiazolidinedione (TZD) was provided by Beijing Jia Rui Period Technological Co., Ltd (China), TZD's purity was 99.62%.

Animals and diets
-----------------

In Experiment 1, a total of 80 castrated male pigs (Large White×Landrace, BW = 54.34±0.22 kg) were randomly divided into two treatments. Each treatment had 5 replicates, and 8 pigs each replicate. The initial body weights were not significantly different between two treatments. The animals in the control group were fed with a basic diet, whereas those in the test group were fed with a basic diet supplemented with 15 mg/kg TZD. In Experiment 2, 80 pigs (Large White×Landrace, BW = 71.46±1.18 kg) were assigned to the two groups as described in Experiment 1, but there were slaughter trials for experiment 2 to measure carcass and meat quality.

Feeding and management
----------------------

Experiment 1 (from November 12, 2008, to December 20, 2008) and Experiment 2 (from May 5, 2009, to July 14, 2009) were both conducted on the livestock farm of South China Agriculture University (Zeng cheng, Guangzhou, China). The adaptation period lasted for 1 wk, and the formal feeding period lasted for 4 wks. The composition of the basic diet is shown in [Table 1](#t1-ajas-26-7-1012-15){ref-type="table"}. The diet and water were offered *ad libitum*. The temperature of the animal house was maintained at 25°C. This study was approved by the South China Agricultural University Animal Care Committee.

Growth performance evaluation
-----------------------------

All of the trial pigs were weighed on the day when the experiment started and, subsequently, once every two weeks. The feed consumption was measured per week. The average daily gain (ADG), average daily feed intake (ADFI) and feed: gain (F:G) ratio were determined every two weeks.

Carcass and meat quality evaluation
-----------------------------------

In Experiment 2, one pig from each replicate was selected to determine the slaughter trial. The carcass characteristics were evaluated by following the Chinese Agriculture Industry Standard NY-T825-2004 (the standard for the detection of the carcass performance of lean pigs) and the procedures of [@b58-ajas-26-7-1012-15].

The meat quality traits of longissimus dorsi muscle were analyzed by following the Chinese Agriculture Industry Standard NY-T821-2004 (the standard for the detection of pigs' meat quality) and the procedures of [@b30-ajas-26-7-1012-15].

The color coordinates was calculated with a Minolta spectrophotometer (MINOLTA, CR-400) (lightness, L\*; redness, a\*; yellowness, b\*). The pH was measured using a combined glass electrode connected to a portable pH meter (DLETA 320, Mettler-Toledo, Shang hai, China). Samples of the longissimus dorsi muscle were obtained for IMF content evaluation according to [@b22-ajas-26-7-1012-15]. Intramuscular fat content was determined using the Soxhlet petroleum-ether extraction method and the results were expressed in a percentage of raw meat weight.

Determination of serum biochemical indices
------------------------------------------

On d 14 and 28, blood samples were obtained through the precaval vein from 2 selected pigs of average weight from each replicate ([@b48-ajas-26-7-1012-15]). Serum was collected at 3,000 r/min for 10 min and stored at −20°C. The concentrations of glucose (GLU), triglyceride (TG), total protein (TP), serum urea nitrogen (SUN) and high density lipoprotein (HDL) were measured with a commercial assay kit (Nanjing Jianchen Biological Product Co. Ltd., China) according to the manufacturer's introductions.

RNA extraction and cDNA synthesis
---------------------------------

Total RNA was extracted from the longissimus dorsi muscle tissue using TRIZOL reagent (Invitrogen, Carlsbad, CA, USA) and treated with DNase I (Invitrogen) according to the manufacturer's instructions. The RNA quality was checked using 1% agarose gel electrophoresis followed by staining with 10 μg/ml ethidium bromide. The RNA had an OD~260~:OD~280~ ratio between 1.8 and 2.0.

The synthesis of the first-strand cDNA was performed for 1 h at 37°C in a reaction volume of 20 μl containing 2 μg of purified total RNA, 5 μmol/L oligo dT (18), 4 μl 5×RT buffer, 1 mmol/L dNTP, 20 U RNase inhibitor (Takara, Dalian) and 200 U reverse transcriptase (MMLV, Promega). The synthesized first-strand cDNA samples were diluted by the addition of ultra-purified water ([@b15-ajas-26-7-1012-15]).

Quantification of mRNA by real-time PCR analysis
------------------------------------------------

Gene expression at the mRNA level was analyzed by quantitative real-time PCR with specific primers designed by Premier5.0 ([Table 2](#t2-ajas-26-7-1012-15){ref-type="table"}). The housekeeping gene GAPDH was used as an internal control. PCR was performed in a 20 μl reaction containing 10 μl 2×SYBR Green Master Mix, 1 μl cDNA template, 1 μl 10 μmol primer and 0.4 μl ROX. After a single pre-denaturation cycle at 95°C for 1 min, the amplification was performed for 35 cycles (95°C for 15 s, 58°C for 15 s, 72°C for 40 s) with a melting curve program (95°C for 1 min, 58°C/62°C for 30 s, 95°C for 30 s). Amplification and melt-curve analysis were performed in Mx3005P (Agilent Stratagene, USA). The relative mRNA abundance of the target genes were evaluated as R = 2^−(Ct(GAPDH)−Ct(target\ gene))^.

Statistical analysis
--------------------

All data were presented as means±SE and were analyzed by independent-samples T-tests using SAS ([@b41-ajas-26-7-1012-15]). Differences between groups were considered statistically significant if p\<0.05, and there was tendency toward statistical significance if p\<0.10.

RESULTS
=======

Effects of TZD on growth performance
------------------------------------

Experiment 1 (the early stage of the finishing pigs): Compared with the control group, the addition of TZD slightly decreased the ADFI by 6.65% and 3.00% (p\<0.10) during 0 to 14 d and 15 to 28 d, respectively ([Table 3](#t3-ajas-26-7-1012-15){ref-type="table"}), and TZD supplementation significantly decreased the ADFI (p\<0.05) of TZD group during 0 to 28 d. TZD also decreased the F:G ratio by 5.13% during 0 to 28 d (p\>0.05), whereas the ADG was not influenced by TZD supplementation (p\>0.05).

Experiment 2 (the late stage of the finishing pigs): Compared with the control group, TZD supplementation resulted in an significant increase in the ADG of TZD group during 14 to 28 d and 0 to 28 d (p\<0.05), moreover, TZD reduced the F:G ratio by 4.00% during 0 to 28 d (p\<0.05). There was no difference in the ADFI between the control and TZD groups (p\>0.05).

Effects of TZD on carcass performance and meat quality
------------------------------------------------------

There were little differences in the measured carcass traits between the control and TZD groups ([Table 4](#t4-ajas-26-7-1012-15){ref-type="table"}), except that pigs in the TZD group had a 5.68% lower lean percentage than that of pigs in the control group, but without significant difference (p\>0.05). In the context of the meat quality traits, TZD supplementation had no effect on water loss (p\>0.05) and pH values (p\>0.05). Pigs fed with TZD had a 6.42% higher a\* value (p\<0.10) than that of those fed with the control diet. The marbling score was increased by 32.18% by TZD supplementation (p\<0.10), and the IMF content was increased by 16.43% (p\<0.10), compared with the control group.

Effects of TZD on serum biochemical indices
-------------------------------------------

In Experiment 2, compared with the control group, TZD supplementation tended to increase the serum TG concentration by 11.11% on d 14 (p\<0.10) and significantly increased the serum TG concentration by 17.24% on d 28 (p\<0.05) ([Table 5](#t5-ajas-26-7-1012-15){ref-type="table"}). Moreover, pigs fed with TZD had higher levels of serum HDL than pigs fed with the control diet on d 28 (p\<0.05). Otherwise, the serum TP concentration was significantly lower in TZD group than the control group (p\<0.05). However, TZD treatment had no effect on the GLU and SUN concentration (p\>0.05).

Effects of TZD on relative mRNA abundance
-----------------------------------------

The adjusted mRNA abundance of PGC-1 was significantly higher in the longissimus dorsi muscle of pigs fed with TZD than that of control animals (p\<0.05) ([Table 6](#t6-ajas-26-7-1012-15){ref-type="table"}). TZD supplementation resulted in an up-regulation of FABP3 expression (a 65.12% increase in mRNA abundance, p\<0.10). There was no difference in the mRNA abundance of GLUT4 between the control group and TZD group (p\>0.05).

DISCUSSIONS
===========

Nutrition redistribution agents have received a lot of attentions in recent years because their great ability to improve human health and animal production. Conjugated linoleic acid (CLA) and Arginine (Arg) are two typical agents of this kind commonly used in the livestock industry. Previous studies have reported CLA can decrease the body fat mass ([@b53-ajas-26-7-1012-15]; [@b44-ajas-26-7-1012-15]; [@b35-ajas-26-7-1012-15]) and increase the lean body mass ([@b21-ajas-26-7-1012-15]; [@b12-ajas-26-7-1012-15]) through suppressing the expression of PPARγ ([@b24-ajas-26-7-1012-15]), inhibiting the convertion of preadipocyte into adipocyte ([@b36-ajas-26-7-1012-15]). Arg has also been reported to have the capacity to decrease the body fat accretion and enhance the muscle gain ([@b19-ajas-26-7-1012-15]; [@b46-ajas-26-7-1012-15]), which involves multiple NO-dependent pathways ([@b25-ajas-26-7-1012-15]), and also correlated to the functions of PPARγ ([@b52-ajas-26-7-1012-15]). These studies suggested the influence of nutrition redistribution agents mainly focused on the muscle and adipose tissues, and generally involved in PPARγ pathways. In the present study, TZD played a crucial role as CLA and Arg in nutritional distribution, as well as in PPARγ pathways related genes expression.

In Experiment 1, dietary TZD supplementation significantly decreased the ADFI without affecting the ADG, whereas in Experiment 2, TZD increased the ADG and lowered the F:G ratio. The results from the Experiment 2 agreed with the findings of [@b37-ajas-26-7-1012-15], which demonstrated that type-2 diabetic patients exhibit a significant increase in the body weight after treatment with dietary pioglitazone for 16 wks. The explanation for this could be that TZD is able to shift the energy balance toward storage, leading to an increase in the whole-body adiposity and the number of small adipocytes ([@b45-ajas-26-7-1012-15]). Combining the results that showed lean percentage of TZD-treated pigs was lower in numerical value; it was presumed the increased ADG in TZD group was mainly due to more adipose deposition in the body. Otherwise, the influence of TZD supplementation on growth performance differed between pigs at different ages. This implied that the effect of TZD was dependent on the growth phase, and the ADG and F:G ratio was more prone to be impacted by TZD in the late phase of finishing pigs.

In the current work, carcass parameters were not affected by TZD supplementation. However, the observed trends towards an effect of TZD on marbling and IMF content in the longissimus dorsi muscle were of high magnitude. The results agreed with the previous studies which observed that the intramuscular lipid accumulation was increased in TZD treated rodents ([@b38-ajas-26-7-1012-15]; [@b50-ajas-26-7-1012-15]; [@b5-ajas-26-7-1012-15]). Importantly, research in pigs has demonstrated that TZD is able to increase the lipid accretion in the muscle ([@b18-ajas-26-7-1012-15]). This might be attributed to the great ability of TZD on adipose differentiation through activating PPARγ ([@b2-ajas-26-7-1012-15]), as [@b49-ajas-26-7-1012-15] has reported the potential of TZD to trans-differentiate C2C12N myoblasts into adipoblasts. The results suggested TZD supplementation has the ability to impact the adipose tissue in the skeletal muscle of pigs. Additionally, TZD increased a\* value by 6.42%, suggesting that the meat products of the TZD group appeared to be redder and more favorable in color.

In Experiment 1, no effect of TZD on serum parameters was found. In Experiment 2, the serum TG concentration was increased both on d 14 and d 28 by TZD supplementation, and the level of serum HDL on d 14 was also higher in TZD treated pigs (p\<0.05), indicating the lipid utilization was increased, otherwise, fat metabolism *in vivo* was improved and shifted toward fatty deposition. This could be correlated with the results that pigs fed with TZD had a higher IMF content and lower lean percentage, which were caused by elevated fatty deposition. There was little difference in the serum GLU concentration between the two groups. However, clinical study demonstrated that diabetic patients treated with TZD have a lower plasma glucose concentration and higher level of GLUT4 expression ([@b37-ajas-26-7-1012-15]). An explanation for this difference might be that TZD influenced the serum glucose concentration only when glucose metabolism *in vivo* is abnormal, and in our study all the trial animals were in healthy situation. These results suggested that TZD had a great effect on serum parameters related to fat metabolism.

PPARγ is predominant in adipocytes differentiation and lipid storage ([@b7-ajas-26-7-1012-15]; [@b43-ajas-26-7-1012-15]), and the adipogenesis begins with the activation of PPARγ in the presence of TZD ([@b55-ajas-26-7-1012-15]). However, PPARγ is primarily expressed in adipose tissue ([@b7-ajas-26-7-1012-15]), therefore, we selected PGC-1, the co-activator of PPARγ, as a mark gene in the experiment. The mRNA abundance of PGC-1 in the longissimus dorsi muscle was significantly increased by TZD supplementation, compared with the control group. The result was consistent with the hypothesis; TZD influenced the fatty deposition and serum parameters through activating the critical gene involved in fat metabolism. Moreover, TZD supplementation increased the mRNA abundance of FABP3 mRNA by 65.12% above that of the control group, indicating an up-regulated transport and accretion of fatty acids in the muscle of TZD-fed animals. This is consistent with the findings of [@b17-ajas-26-7-1012-15] showing that a TZD treatment of the obese Zucker rat induced a marked increase in weight gain, and stimulated the expression of genes necessary for lipid metabolism. Moreover, it has been reported the expression of FABP3 was positively correlated with the IMF content ([@b8-ajas-26-7-1012-15]), thus the increased IMF levels in the TZD group could be associated with the up-regulated expression of FABP3. There was no difference in the mRNA abundance of GLUT4 between the control and TZD groups, which was inconsistent with the findings of other researches ([@b17-ajas-26-7-1012-15]; [@b37-ajas-26-7-1012-15]). It suggested TZD had no effect on glucose utilization when it was supplemented for healthy animals.

In summary, like other nutrition redistribution agents ([@b31-ajas-26-7-1012-15]), TZD exhibited its effect through involving PPARγ or the related genes, targeting the adipose tissue. Moreover, TZD has the potential to be a new nutrition redistribution additive used to improve meat quality because TZD could increase marbling score and IMF content in meat animals, which has also been reported in researches about Arg, a above mentioned nutrition redistributor ([@b46-ajas-26-7-1012-15]; [@b32-ajas-26-7-1012-15]; [@b47-ajas-26-7-1012-15]; [@b59-ajas-26-7-1012-15]). As a PPARγ agonist, it has been reported TZD could activate PPARγ in adipocytes ([@b40-ajas-26-7-1012-15]). In the present study, TZD could activate PGC-1, and up-regulate its expression in muscle cells or adipocytes in muscle adipose tissue of the TZD-treated pigs, subsequently the expression of the downstream genes such as FABP3, which involved in PPARγ pathway, will be increased to enlarge the effect of TZD supplementation. In the physiological levels, it was hypothesized the up-regulated expressions of these genes promoted the accretion of fatty acids in the muscle, increased serum TG and HDL concentrations, thus inducing a more active fat metabolism *in vivo* and the tendency towards adipose deposition. Otherwise, insulin sensitivity might be improved by the activation of PPARγ, which has been reported in rodents and humans, through a combination of metabolic actions, which promoted the deposition of the nutrients and partitioning of lipid stores ([@b51-ajas-26-7-1012-15]). Finally, these changes contribute to the improvement of growth performance and the elevated IMF content, which might be correlated to the increased adipose deposition in the whole body.

CONCLUSION
==========

Dietary TZD supplementation could increase the ADG and decrease the F:G ratio, and elevate the serum TG and HDL levels, importantly, had a positive effect on marbling score and IMF content, which was related with PGC-1 and FABP3, the genes involved in fat metabolism. In addition, the effects of TZD was significant in the late phase of finishing pigs, but not obvious in the early phase.

This work was supported by National Major Science Research Program of China (2012CB124704), National 948 Program of China (2011-G35), Special Fund for Public Welfare Industry of China (Agriculture, 201003011), Education Department Key Project of Guangdong Province (2012CXZD0015), and Science and Technology Planning Project of Guangdong Province, China (2012B020305006, 2011B090400190).

###### 

The ingredients composition and nutritional levels of the basic diet

  Ingredients %                                               Exp. 1 (50--70 kg)   Exp. 2 (70--90 kg)
  ----------------------------------------------------------- -------------------- --------------------
  Corn                                                        68                   68
  Soybean meal                                                23                   20
  Wheat bran                                                  0                    8
  Apple meal                                                  5                    0
  Premix[^1^](#tfn1-ajas-26-7-1012-15){ref-type="table-fn"}   4                    4
  Nutritional levels                                                               
    DE MJ/kg                                                  13.31                13.14
    CP (%)                                                    15.56                15.16
    Ca (%)                                                    0.70                 0.68
    P (%)                                                     0.47                 0.52
    Lys (%)                                                   0.81                 0.76
    Met+cys (%)                                               0.49                 0.47

Mineral and vitamin premix provided are as follows per kilogram of diet: Vitamin A 3,600 IU, Vitamin D~3~ 680 IU, Vitamin E 3 mg, Vitamin K~3~ 0.52 mg, Vitamin B~1~ 1 mg, Vitamin B~2~ 2 mg, Vitamin B~6~ 1 mg, Vitamin B~12~ 2 mg, Niacin 7 mg, D-calcium pantothenate 7 mg, Choline chloride 0.3 g, Folic acid 0.3 mg, Copper 12 mg, Iron 60 mg, Manganese 8 mg, Zinc 48 mg.

###### 

Parameters of primer pairs for PGC-1, GLUT4, FABP3 and GAPDH

  Genes          Localization                   Primer sequence                Product (bp)   Tm (°C)
  -------------- ------------------------------ ------------------------------ -------------- ---------
  PGC-1          1,004--1,021                   F 5′-GCCAACCAAGATAACCC-3′      107            62
  1,093--1,110   R 5′-GTCCCCGAAGACTCACT-3′                                                    
  GLUT4          1,341--1,361                   F 5′-TGAGTTTCCAGTATGTTGCG-3′   107            58
  1,447--1,467   R 5′-GGTTTCAGGCACTTTTAGGA-3′                                                 
  FABP3          209--229                       F 5′-AGCACCTTCAAGAGCACAGA-3′   147            62
  320--340       R 5′-CAAGTTTGCCTCCATCCAGT-3′                                                 
  GAPDH          350--369                       F 5′-GGTCGGAGTGAACGGATTTG-3′   170            58
  500--519       R 5′-CCTTGACTGTGCCGTGGAAT-3′                                                 

###### 

The effect of TZD supplementation on growth performance of finishing pigs

  Item             Period                                                           Exp.1           Exp.2                                                                         
  ---------------- ---------------------------------------------------------------- --------------- -------------- -------------------------------------------------------------- --------------
  ADFI (g/pig/d)   0--14 d                                                          2,483.3±108.0   2,318.3±15.0   2,268.5±57.4                                                   2,252.8±14.0
  15--28 d         2,554.5±64.0                                                     2,477.8±30.7    2,619.3±93.1   2,680.5±54.0                                                   
  0--28 d          2,518.9±27.1[\*](#tfn2-ajas-26-7-1012-15){ref-type="table-fn"}   2,398.0±8.7     2,443.9±59.8   2,466.7±27.3                                                   
  ADG (g/pig/d)    0--14 d                                                          748.9±34.6      726.8±32.2     687.3±21.7                                                     693.6±13.4
  15--28 d         694.5±41.4                                                       715.9±17.8      796.2±17.3     871.9±18.3[\*](#tfn2-ajas-26-7-1012-15){ref-type="table-fn"}   
  0--28 d          721.7±17.7                                                       721.4±24.9      752.4±10.6     791.0±12.9[\*](#tfn2-ajas-26-7-1012-15){ref-type="table-fn"}   
  F:G              0--14 d                                                          3.33±0.18       3.20±0.16      3.27±0.11                                                      3.26±0.09
  15--28 d         3.71±0.25                                                        3.46±0.05       3.30±0.11      3.09±0.06                                                      
  0--28 d          3.51±0.06                                                        3.33±0.10       3.25±0.04      3.12±0.02[\*](#tfn2-ajas-26-7-1012-15){ref-type="table-fn"}    

Data are expressed as means±SE, n = 5. In Exp. 1 or Exp. 2, values with \* within same line were significantly different (p\<0.05), values with different letters within same line was tendency toward statistical significance (p\<0.10).

###### 

The effect of TZD supplementation on carcass performance and meat quality (n = 5)

  Item                                                  Control         TZD
  ----------------------------------------------------- --------------- ---------------
  Dressing percentage (%)                               72.47±0.74      73.35±0.33
  Lean percentage (%)                                   59.32±1.35      55.95±1.89
  Backfat thickness (mm)                                27.42±3.43      26.03±2.75
  Eye muscle area (mm^2^)                               46.68±3.86      45.05±5.36
  L[\*](#tfn4-ajas-26-7-1012-15){ref-type="table-fn"}   45.09±1.72      42.53±2.79
  a[\*](#tfn4-ajas-26-7-1012-15){ref-type="table-fn"}   13.85±0.32^b^   14.74±0.42^a^
  b[\*](#tfn4-ajas-26-7-1012-15){ref-type="table-fn"}   0.20±0.03       0.18±0.02
  Water loss (%)                                        5.53±0.51       4.92±0.51
  pH~45min~                                             6.09±0.09       6.23±0.14
  pH~24h~                                               5.51±0.04       5.44±0.06
  Marbling score                                        1.74±0.12^b^    2.30±0.25^a^
  Intramuscular fat (%)                                 1.40±0.11^b^    1.63±0.04^a^

Data are expressed as means±SE, n = 5.

Values with \* within same line were significantly different (p\<0.05), values with different letters within same linw was tendency toward statistical significance (p\<0.10).

###### 

The effect of TZD supplementation on index of blood serum of finishing pigs

  Item           Period       Exp. 1                                                  Exp. 2                                                                      
  -------------- ------------ ------------------------------------------------------- ------------ -------------------------------------------------------------- -------------------------------------------------------------
  GLU (mmol/L)   14 d         4.54±0.45                                               4.93±0.20    3.31±0.12                                                      3.30±0.18
  28 d           4.13±0.20    4.24±0.45                                               3.20±0.13    3.19±0.18                                                      
  SUN (mmol/L)   14 d         6.56±1.05                                               4.30±0.52    5.36±0.24                                                      5.11±0.19
  28 d           6.38±0.97    4.38±0.44                                               6.05±0.29    6.43±0.33                                                      
  TP (g/L)       14 d         70.25±1.71                                              64.96±1.09   86.79±2.50[\*](#tfn5-ajas-26-7-1012-15){ref-type="table-fn"}   77.74±1.87
  28 d           72.37±2.37   67.87±3.82                                              77.44±2.55   74.43±0.69                                                     
  TG (mmol/L)    14 d         0.32±0.03                                               0.32±0.04    0.54±0.03^b^                                                   0.60±0.02^a^
  28 d           0.36±0.03    0.32±0.02                                               0.58±0.03    0.68±0.03[\*](#tfn5-ajas-26-7-1012-15){ref-type="table-fn"}    
  HDL (mmol/L)   14 d         ND[^1^](#tfn6-ajas-26-7-1012-15){ref-type="table-fn"}   ND           0.71±0.04                                                      0.83±0.02[\*](#tfn5-ajas-26-7-1012-15){ref-type="table-fn"}
  28 d           ND           ND                                                      0.72±0.05    0.76±0.04                                                      

Data are expressed as means±SE, n = 10. In Exp. 1 or Exp. 2, values with \* within same line were significantly different (p\<0.05), values with different letters within same line was tendency toward statistical significance (p\<0.10).

ND = Not detected.

###### 

mRNA abundance of related genes in the longissimus dorsi muscle^[1](#tfn9-ajas-26-7-1012-15){ref-type="table-fn"},[2](#tfn10-ajas-26-7-1012-15){ref-type="table-fn"}^

  Gene    Control            TZD
  ------- ------------------ -----------------------------------------------------------------
  PGC-1   0.0061±0.0006      0.0237±0.0070[\*](#tfn8-ajas-26-7-1012-15){ref-type="table-fn"}
  FABP3   0.0860±0.0087^b^   0.1420±0.0356^a^
  GLUT4   0.0711±0.0157      0.0753±0.0147

Data are expressed as means±SE, n = 5.

Values with \* within same line were significantly different (p\<0.05), values followed by different letters is considered there was tendency toward statistical significance (p\<0.10).

mRNA abundance for each target gene relative to glyceraldehyde-3-phosphate dehydrogenase expression.

PGC-1 = PPARγ coactivator 1; FABP3 = Fatty acid-binding protein 3; GLUT4 = Glucose transporter 4.
